Related Experiment Video
Updated: Jun 13, 2025
14:32
Deacetylation Assays to Unravel the Interplay between Sirtuins SIRT2 and Specific Protein-substrates
Published on: February 27, 2016
8.3K
Lock out SIRT4
Kaiqiang Zhao1, Zhongjun Zhou1
1School of Biomedical Sciences, University of Hong Kong, Hong Kong, Hong Kong.
Elife
|September 13, 2024
Abstract:
The accumulation of SIRT4 in the nuclei of kidney cells drives kidney fibrosis, so blocking the movement of this protein could be a potential therapeutic strategy against fibrosis.
Insights
Kidney cell nuclear accumulation of SIRT4 protein drives kidney fibrosis. Blocking SIRT4 movement offers a potential therapeutic strategy to combat this fibrotic condition.
Area of Science:
- Nephrology
- Cell Biology
- Molecular Medicine
Background:
- Kidney fibrosis is a significant contributor to chronic kidney disease progression.
- The precise molecular mechanisms driving kidney fibrosis remain incompletely understood.
- Sirtuin 4 (SIRT4) is implicated in cellular metabolic regulation.
Purpose of the Study:
- To investigate the role of SIRT4 in the pathogenesis of kidney fibrosis.
- To determine the subcellular localization of SIRT4 in kidney cells during fibrosis.
- To explore the potential of targeting SIRT4 nuclear translocation as a therapeutic approach for kidney fibrosis.
Main Methods:
- Utilized kidney cell culture models and animal models of kidney fibrosis.
- Employed immunofluorescence and Western blotting to assess SIRT4 protein levels and localization.
- Investigated the effects of inhibiting SIRT4 nuclear import on fibrotic markers.
Main Results:
- SIRT4 was found to accumulate in the nuclei of kidney cells in fibrotic conditions.
- Nuclear accumulation of SIRT4 correlated with increased expression of fibrotic markers.
- Inhibition of SIRT4 nuclear translocation attenuated the development of kidney fibrosis.
Conclusions:
- Nuclear accumulation of SIRT4 is a key driver of kidney fibrosis.
- Targeting SIRT4 nuclear export or import represents a promising therapeutic strategy for kidney fibrosis.
- Further research into SIRT4-mediated pathways is warranted for developing novel anti-fibrotic therapies.
Related Concept Videos
01:52Eukaryotic Transcription Inhibitors
9.8K
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
9.8K
01:45Regulation of Nuclear Protein Sorting
2.4K
Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
2.4K
01:20The JAK-STAT Signaling Pathway
8.7K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.7K
01:16TGF - β Signaling Pathway
7.3K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.3K
01:31Regulation of the Unfolded Protein Response
2.4K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.4K
01:22PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K